Endometriosis [ Abridged ]
article
OA: bronze
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study treated 41 endometriosis patients with oral progestogens, observing improvement in 22 of 28 preoperative cases and all 18 postoperative cases.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
41 patients were treated for endometriosis with an oral progestogen in most cases norethisterone acetate. In preoperative cases treatment was administered both continously and cyclically depending upon the incursion of side effects. In 22 out of 28 women given preoperative treatment improvement was seen before laparotomy. In postoperative treatment without previous hormone therapy all 18 cases improved whether due to surgery and/or therapy. It was undetermined if the decidual reaction followed by necrosis was the effective mechanism of the progestogens.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (7)
- Current pharmacotherapy for endometriosis 2010
- The role of progestins in treating the pain of endometriosis 2006
- Current place of progestins in the treatment of endometriosis-related complaints 2001
- Progestins for symptomatic endometriosis: a critical analysis of the evidence 1997
- Recurrent endometriosis: Incidence, management, and prognosis 1983
- Management of Endometriosis in the Infertile Patient 1975
- Colorectal endometriosis 1973
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-14T05:59:23.748286+00:00
License: CC0
· commercial use OK